The Patent Finder
US

Gene Therapy Vectors for Adrenoleukodystrophy and Adrenomyeloneuropathy

US 8,858,928 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Bluebird Bio, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Jun 8, 2032 · High confidence

Filed Jun 8, 2012 as application 13/492,553 · Granted Oct 14, 2014
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Jun 8, 2012
Term ends
Jun 8, 2032
Granted
Oct 14, 2014
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 8, 2012, when this application, 13/492,553, was filedJun 8, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 8, 2032High confidence

This family

US 8,858,928this patent
Jun 2032
Jun 2032
US 9,061,031In force
no later than Jun 2032
no later than Jun 2032
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 21, 2012
Reel 29003, frame 671
Denaro, Maria Joann; Finer, Mitchell Howard; Veres, GaborBluebird Bio, Inc.Assignment of Assignor's Interest
Jun 27, 2014
Reel 33196, frame 515
Down, JulianBluebird Bio, Inc.Assignment of Assignor's Interest
Mar 15, 2024
Reel 66801, frame 818
Bluebird Bio, Inc.Hercules Capital, Inc., as AgentSecurity Interest
Sep 25, 2025
Reel 72955, frame 154
Bluebird Bio, Inc.Genetix Biotherapeutics Inc.Change of Name
Nov 2, 2026
Reel 76600, frame 706
Hercules Capital, Inc., as AgentGenetix Biotherapeutics Inc. (F/K/A Bluebird Bio, Inc.)Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited